Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 137,540 | 135,006 | 126,011 | 119,087 | 116,784 |
| Cost of Goods | 24,570 | 25,157 | 22,735 | 23,020 | 23,567 |
| Gross Profit | 112,970 | 109,849 | 103,276 | 96,067 | 93,217 |
| Operating Expenses | 95,415 | 91,468 | 86,949 | 81,596 | 78,440 |
| Operating Income | 18,125 | 18,538 | 17,062 | 14,491 | 15,344 |
| Interest Expense | 26 | 42 | 5 | 21 | 69 |
| Other Income | 371 | 593 | -582 | 360 | 111 |
| Pre-tax Income | 18,470 | 19,089 | 16,475 | 14,830 | 15,386 |
| Income Tax | 6,079 | 6,240 | 5,705 | 5,189 | 5,179 |
| Net Income Continuous | 12,391 | 12,849 | 10,770 | 9,641 | 10,207 |
| Net Income | $12,391 | $12,849 | $10,770 | $9,641 | $10,207 |
| EPS Basic Total Ops | 0.39 | 0.42 | 0.35 | 0.32 | 0.34 |
| EPS Basic Continuous Ops | 0.39 | 0.41 | 0.35 | 0.31 | 0.33 |
| EPS Diluted Total Ops | 0.38 | 0.40 | 0.35 | 0.31 | 0.33 |
| EPS Diluted Continuous Ops | 0.38 | 0.40 | 0.34 | 0.31 | 0.33 |
| EBITDA(a) | $20,400 | $20,556 | $18,881 | $16,295 | $17,101 |